Microsaic Systems plc (AIM: MSYS), the high technology company developing the next generation of miniaturised mass spectrometry (MS) instruments, is pleased to announce that its product range is now compatible with Clarity Chromatography Software, the advanced Chromatography Data Station developed by Data Apex. The Clarity software interface includes control modules for data acquisition, processing and […]

Melbourne, Australia: Trajan Scientific and Medical (Trajan) continues to expand their technical and research capabilities, announcing a landmark agreement with academia and government in Australia today. Trajan’s latest strategic collaboration with the University of Adelaide, supported by the South Australian Government, sees the realization of a research and development and manufacturing hub based on a […]

Applied DNA Sciences has acquired the assets of privately held Vandalia Research, Inc. for $1.5 million in cash. Vandalia’s core technology and intellectual property portfolio, allow for the large-scale production of specific DNA sequences using polymerase chain reaction (PCR). PCR can amplify a few copies of a piece of DNA, generating millions to billions of […]

Jerusalem and Cambridge, Mass. – IBM (NYSE: IBM) Watson Health and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Teva has been selected as its first Foundational Life Sciences Partner for the Watson Health Cloud. As part of this new strategic partnership, Teva becomes the first global pharmaceutical company to tap the […]

CAMBRIDGE, MA – Opening its new IBM Watson Health global headquarters in Cambridge, Mass., IBM (NYSE: IBM) today announced that Deborah DiSanzo is joining the company as the business unit’s General Manager, introduced a pair of new cloud services, and revealed major new partnerships — all reflecting IBM’s commitment to helping advance the quality of […]

Oxford, England — Genomics and proteomics-based research and diagnostics company Sengenics today announced its acquisition of Oxford Gene Technology’s (OGT) protein array technology, a patented auto-antibody profiling platform which was spun out from research that was commercialised as a joint collaboration between the University of Oxford and the University of Cambridge in 1996. It is […]

SANTA CLARA, Calif., and BILLERICA, Mass. — Agilent Technologies Inc. (NYSE: A) and Seahorse Bioscience today announced they have signed a definitive agreement under which Agilent will acquire Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Exploration into cell metabolism is rapidly accelerating as the links between […]

Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the international life science company supplying research tools and services that power genomics research and the development of personalised medicines, and Abcam plc (AIM: ABC), a global leader in the supply of research antibodies, today announced the formation of a license and supply […]

Austin, Texas –– Asuragen, Inc., a global molecular diagnostics company, announced today that it had entered into a collaboration agreement with Illumina, Inc. (NASDAQ:ILMN) that establishes a framework for the development and commercialization of sequencing-based companion diagnostics in partnership with biotech and pharmaceutical companies. Asuragen will leverage its Quantidex™ NGS product platform for development of […]

Torrance, Calif. and Männedorf, Switzerland – Phenomenex, Inc. and the Tecan Group (SIX Swiss Exchange: TECN) today announced a collaboration to co-market automated solid phase extraction (SPE) sample preparation solutions. The two companies will jointly market Phenomenex Strata™ and Strata-X SPE sorbents adapted to Tecan’s Freedom EVO® series of robotics workstations. The solution is especially […]